Drug · DIN 02236859
AGRYLIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 19, 2024; first marketed January 6, 1998.
- Drug Identification Number (DIN)
- 02236859
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Anagrelide L01XX35
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANAGRELIDE (ANAGRELIDE HYDROCHLORIDE) | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 7, 2021: NOC 26225New Drug Submission (NDS) · Update the Product Monograph to the 2020 format Administrative: Merger/Buy-out
- March 9, 2015: NOC 16676New Drug Submission (NDS) · Manufacturer name change
- October 16, 2007: NOC 9096New Drug Submission (NDS) · Manufacturer name change
- July 21, 2003: NOC 70New Drug Submission (NDS)
- March 3, 2000: NOC 978New Drug Submission (NDS)
- November 19, 1997: NOC 3282New Drug Submission (NDS)